Health Information Management

Tip: Note latest APCs added to I/OCE

APCs Insider, October 17, 2014

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

CMS added these four APCs in the latest I/OCE update, effective October 1:
  • 1487, injection, testosterone undecanoate, 1 mg, assigned to HCPCS C9023
  • 1488, injection, ramucirumab, 5 mg, assigned to HCPCS C9025
  • 1489, injection, vedolizumab, 1 mg, assigned to HCPCS C9026
  • 1486, factor IX (antihemophilic factor, recombinant), Alprolix, per i.u., assigned to HCPCS C9135
CMS will change the status indicators for two HCPCS codes from K (paid under OPPS; separate APC payment) to E (not paid by Medicare when submitted on outpatient claims [any outpatient bill type]), effective October 1:
  • J9160, injection, denileukin diftitox, 300 micrograms
  • J9300, injection, gemtuzumab ozogamicin, 5 mg
The APCs for denileukin diftitox (01084) and gemtuzumab ozogamicin (9004) have been deleted.
 
This tip is adapted from “MACs to reprocess radiosurgery claims due to copayment miscalculation” in the October issue of Briefings on APCs.



Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular